Acitretin revisited in the era of biologics
- 1 August 2010
- journal article
- review article
- Published by Informa UK Limited in Journal of Dermatological Treatment
- Vol. 22 (2), 86-89
- https://doi.org/10.3109/09546630903578582
Abstract
Acitretin is a time-honored treatment for psoriasis. During the last decade biologics have revolutionized the treatment of psoriasis. This raises the question: What is the position of acitretin as a classical systemic treatment for psoriasis in the era of biologics? Based on the mode of action of acitretin, it is evident that at least one antipsoriatic treatment has to be available in the armamentarium of antipsoriatic treatments that is not immunosuppressive, intended for those patients who are contraindicated for immunosuppressive treatment. It is attractive to speculate that at least an additive or possibly a synergistic effect can be expected in case of combination of acitretin with a biologic. The efficacy of acitretin in chronic plaque psoriasis as a monotherapy is below methotrexate and cyclosporine. However, acitretin in combination with phototherapy has an efficacy at least comparable with the other classical systemic treatments. Based on several clinical studies it can be concluded that acitretin is an important treatment option in case of contraindications for immunosuppression, such as patients with infections or cancer-prone patients. Furthermore, some evidence is available for high efficacy of the combination of acitretin and biologics.Keywords
This publication has 14 references indexed in Scilit:
- British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009British Journal of Dermatology, 2009
- Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trialBritish Journal of Dermatology, 2008
- Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION)British Journal of Dermatology, 2007
- Reciprocal T H 17 and Regulatory T Cell Differentiation Mediated by Retinoic AcidScience, 2007
- Interaction between Genetic Control of Vascular Endothelial Growth Factor Production and Retinoid Responsiveness in PsoriasisJournal of Investigative Dermatology, 2006
- Novel combination regimens: Biologics and acitretin for the treatment of psoriasis – a case seriesJournal of Dermatological Treatment, 2006
- A 12-month treatment of severe psoriasis with acitretin: Results of a Canadian open multicenter studyJournal of the American Academy of Dermatology, 1991
- A double-blind comparison of acitretin and etretinate in combination with bath PUVA in the treatment of extensive psoriasisBritish Journal of Dermatology, 1989
- Side-effect profile of acitretin therapy in psoriasisJournal of the American Academy of Dermatology, 1989
- Randomized Double-Blind Multicenter Study Comparing Acitretin-PUVA, Etretinate-PUVA and Placebo-PUVA in the Treatment of Severe PsoriasisDermatology, 1988